Ibrance 125 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26FV701
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,221
Award facts
- Contract value 100% obligated
- $34,220.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,220.84 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of Ibrance 125 mg tablets in quantities of seven per unit. This is a non-set-aside contract with a completion date of February 11, 2026, and performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including military treatment facilities and the Defense Health Agency.
This delivery order is issued under Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031), which provides a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. Ibrance, an oncology medication, represents the type of specialty pharmaceutical product routinely procured through this contract vehicle, which encompasses brand-name and generic drugs, vaccines, and critical care materials across multiple therapeutic domains. The award reflects DLA's continued reliance on Amerisourcebergen as a key pharmaceutical prime vendor for federal medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FV701?
SPE2DR26FV701 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV701 worth?
The government has obligated $34,221 on SPE2DR26FV701.
Is contract SPE2DR26FV701 an order under another contract?
Yes. SPE2DR26FV701 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV701 competed?
The extent of competition for SPE2DR26FV701 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award